Dr. Reddy’s API plant still struggling to satisfy FDA

10th February 2020 Uncategorised 0

Dr. Reddy’s has spent nearly five years trying to get out from under a warning letter for an important API plant in India but has yet to shake off all of the FDA’s concerns. In fact, a new FDA filing raises new concerns about out-of-spec drugs and cleaning of solvents off equipment at the plant.  

More: Dr. Reddy’s API plant still struggling to satisfy FDA
Source: fierce